Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 12, p. 6325, doi. 10.3390/ijms22126325
- By:
- Publication type:
- Article